Bcl-2 inhibition leads to the blockage of late stage autophagy in CRC cells [45]. The antisense oligonucleotide of Bcl-2 sensitizes Bcl-2-positive human colon cancer cells to radiation [40]. Here, BCL2 is linked to colorectal carcinoma.